Development and Preliminary Evaluation of TFIB, a New Bimodal Prosthetic Group for Bioactive Molecule Labeling

[Image: see text] The new readily available prosthetic group, tetrafluorophenyl 4-fluoro-3-iodobenzoate (TFIB), designed for both molecular imaging and targeted radionuclide therapy purposes was radiolabeled either with fluorine or iodine radionuclides with excellent radiochemical yields and puritie...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:ACS Med Chem Lett
Main Authors: Billaud, Emilie M. F., Vidal, Aurélien, Vincenot, Amélie, Besse, Sophie, Bouchon, Bernadette, Debiton, Eric, Miot-Noirault, Elisabeth, Miladi, Imen, Rbah-Vidal, Latifa, Auzeloux, Philippe, Chezal, Jean-Michel
Formato: Artigo
Idioma:Inglês
Publicado em: American Chemical Society 2014
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4329574/
https://ncbi.nlm.nih.gov/pubmed/25699145
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/ml500423v
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados